Keybank National Association OH acquired a new stake in shares of DocGo Inc. (NASDAQ:DCGO – Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 19,650 shares of the company’s stock, valued at approximately $170,000.
Several other institutional investors and hedge funds have also bought and sold shares of the business. BlackRock Inc. lifted its stake in DocGo by 0.3% during the 3rd quarter. BlackRock Inc. now owns 5,387,904 shares of the company’s stock valued at $53,447,000 after acquiring an additional 16,630 shares during the period. State Street Corp lifted its stake in DocGo by 8.4% during the 3rd quarter. State Street Corp now owns 1,799,177 shares of the company’s stock valued at $17,848,000 after acquiring an additional 139,173 shares during the period. Portolan Capital Management LLC lifted its stake in DocGo by 181.1% during the 4th quarter. Portolan Capital Management LLC now owns 1,766,399 shares of the company’s stock valued at $12,488,000 after acquiring an additional 1,138,087 shares during the period. Geode Capital Management LLC lifted its stake in DocGo by 3.7% during the 4th quarter. Geode Capital Management LLC now owns 1,508,879 shares of the company’s stock valued at $10,667,000 after acquiring an additional 53,815 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of DocGo by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 1,049,027 shares of the company’s stock valued at $9,704,000 after purchasing an additional 14,704 shares in the last quarter. 48.58% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
DCGO has been the subject of several recent research reports. Northland Securities lifted their target price on shares of DocGo from $15.00 to $16.00 in a report on Tuesday, August 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $14.00 target price on shares of DocGo in a report on Tuesday. Stifel Nicolaus reissued a “buy” rating and set a $12.00 price target on shares of DocGo in a research report on Monday, July 31st. Finally, BTIG Research began coverage on shares of DocGo in a research report on Friday, August 18th. They issued a “buy” rating and a $15.00 target price on the stock.
Insiders Place Their Bets
In related news, insider Adriaan Stephanus Oberholzer sold 42,497 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $9.07, for a total transaction of $385,447.79. Following the sale, the insider now directly owns 1,243,413 shares in the company, valued at $11,277,755.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other DocGo news, General Counsel Ely D. Tendler sold 10,000 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $8.75, for a total value of $87,500.00. Following the transaction, the general counsel now directly owns 23,088 shares in the company, valued at $202,020. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Adriaan Stephanus Oberholzer sold 42,497 shares of the stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $9.07, for a total transaction of $385,447.79. Following the completion of the transaction, the insider now owns 1,243,413 shares in the company, valued at $11,277,755.91. The disclosure for this sale can be found here. Insiders have sold 124,168 shares of company stock worth $1,178,512 over the last three months. Company insiders own 13.78% of the company’s stock.
DocGo Stock Down 0.8 %
Shares of NASDAQ:DCGO opened at $8.76 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.56 and a quick ratio of 2.56. The firm has a market capitalization of $909.20 million, a PE ratio of 125.14 and a beta of 0.88. The firm’s 50-day moving average is $9.16 and its two-hundred day moving average is $8.91. DocGo Inc. has a 1 year low of $6.36 and a 1 year high of $11.41.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
- Five stocks we like better than DocGo
- Best Stocks Under $5.00
- Can These 2 Industrial Titans Extend Double-Digit YTD Growth?
- Are Stock Buybacks Good for the Average Investor?
- How to Profit from These 3 Membership Club Stocks’ Strengths
- How to Invest in Pharmaceutical Companies
- 5 Best High-Yield Dividend Stocks for Any Economic Climate
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.